secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-03-26T23:59:59+00:00
Accession:  0001493152-26-012812
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emory performs first robotic PAE and Y-90 mapping using Microbot's LIBERTY System
--------------------------------------------------------------------------------

- World's first robotic prostate artery embolization (PAE) for BPH performed with LIBERTY at Emory.
- First robotic Y-90 radioembolization mapping for liver cancer completed using the same system.
- LIBERTY is FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
- Limited Market Release started November 2025; Full Market Release planned for April 2026 at SIR conference.
- BPH affects approximately 40 million men in the U.S.; LIBERTY aims to become standard of care for PAE.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226012812/0001493152-26-012812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226012812/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-012812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer